by admin | Apr 19, 2024 | Article
Please note that as the COVID-19 landscape continues to evolve, information is regularly updated and the links may expire and/or be replaced. Alberta• COVID-19 Information for Albertans British Columbia• Latest information on COVID-19 in BC ...
by admin | Apr 19, 2024 | Article
January 11, 2024 – NOTICE IS HEREBY GIVEN, that Lupus Canada will host its 2024 Annual General Meeting on Tuesday February 13th, 2024 at 6:30pm EST via Zoom. Lupus Canada is inviting you to a scheduled Zoom meeting. Topic: Lupus Canada AGMTime: Feb 13,...
by admin | Apr 19, 2024 | Article
March 6, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Nova Scotia effective March 1, 2024. The public notice and listing criteria will appear on the Nova Scotia Pharmacare Programs website when the March Bulletin is...
by admin | Apr 19, 2024 | Article
March 10, 2024 – Lupus Canada is pleased to share that Saphnelo has been listed in Manitoba effective April 1, 2024. For more information, please visit https://www.gov.mb.ca/health/mdbif/docs/bulletins/bulletin131.pdf
by admin | Apr 19, 2024 | Article
February 1, 2024 – Benlysta, a prescription drug used to treat adults with lupus as well as adults with lupus-related kidney inflammation (active lupus nephritis), has been included in the latest update of RAMQ’s list of medications published on February 1, 2024....
